Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Contracts Finder |
| Notice Type: | Award notice |
| Buyer: | Department of Health and Social Care (London) |
| Main Category: | Services |
| Procurement Method: | Open procedure (above threshold) |
| Tender Status: | Closed |
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
19 August 2024
Closed
Estimated Value
£249,876
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| Estimated Value (ex. VAT): |
| £249,876 |
| Release Date: | 14 October 2024 |
| Application Deadline: | 19 August 2024 |
| Contract Start Date: | 13 October 2024 |
| Contract End Date: | 13 April 2026 |
| Contract Duration: | 1.5 years |
| Procurement ID (OCID): | ocds-b5fd17-573cf6bd-1284-4783-b3d3-dcb9946cea62 |
| Notice Reference: | c47e6038-e793-46cb-9c69-145b4179873b-793626 |
All 2 notices for this procurement, oldest first.
HPV Self-sampling cost effectiveness model
HPV Self-sampling cost effectiveness model
Earlier notices predate the Procurement Act 2023 (commenced 24 Feb 2025) and therefore don't carry UK1–UK17 codes.
View Original Notice
Access the full notice on the official portal
Awarded to
| Award value: | £299,852 |
| Award decision date: | 13 October 2024 |
| Award status: | Active |
The HPV self-sampling ISE will offer a portion of women eligible for cervical screening in England the choice between a clinician taken sample and a self-sample for HPV. The UK NSC has appointed the University of Sydney to undertake a piece of cost-effectiveness modelling to understand the conditions under which harms will outweigh benefits for the offer of HPV self-sampling in the UK. This is particularly important given that testing for HPV on a vaginal/urine self-sample could be slightly less sensitive than a clinician taken cervical sample. Therefore, modelling is required to understand how the self-sampling offer under different uptake scenarios could impact on the number of screen-detected HPV and treated cervical lesion. Contract term: 18 months with the option to extend for a period of up to 6 months. Contract value (including extensions): £249,876 excluding VAT (£299,852 including VAT).
Published contracts in the last 12 months
3
total contracts
£1.3m
total value
£426,667
average contract size
Typical categories
DHSC: PCP: Fluoridation Engineering Support
Department of Health and Social Care (London) · WAC-373332
DHSC: PCP: Fluoridation Engineering Support
Department of Health and Social Care (London) · WAC-380116
Mental Health Approval Function Services 2025-30
Department of Health and Social Care (London) · WAC-384781